BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

134 related articles for article (PubMed ID: 12745435)

  • 1. Cell adhesion induces the plasminogen activator inhibitor-1 gene expression through phosphatidylinositol 3-kinase/Akt activation in anchorage dependent cells.
    Chang H; Shyu KG; Lin S; Wang BW; Liu YC; Lee CC
    Cell Commun Adhes; 2002; 9(5-6):239-47. PubMed ID: 12745435
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Osteopontin stimulates cell motility and nuclear factor kappaB-mediated secretion of urokinase type plasminogen activator through phosphatidylinositol 3-kinase/Akt signaling pathways in breast cancer cells.
    Das R; Mahabeleshwar GH; Kundu GC
    J Biol Chem; 2003 Aug; 278(31):28593-606. PubMed ID: 12771144
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The plasminogen activator inhibitor-1 gene is induced by cell adhesion through the MEK/ERK pathway.
    Chang H; Shyu KG; Lin S; Tsai SC; Wang BW; Liu YC; Sung YL; Lee CC
    J Biomed Sci; 2003; 10(6 Pt 2):738-45. PubMed ID: 14631113
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The inflammatory cytokine oncostatin M induces PAI-1 in human vascular smooth muscle cells in vitro via PI 3-kinase and ERK1/2-dependent pathways.
    Demyanets S; Kaun C; Rychli K; Rega G; Pfaffenberger S; Afonyushkin T; Bochkov VN; Maurer G; Huber K; Wojta J
    Am J Physiol Heart Circ Physiol; 2007 Sep; 293(3):H1962-8. PubMed ID: 17604327
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Phosphatidylinositol 3-kinase/Akt regulates the balance between plasminogen activator inhibitor-1 and urokinase to promote migration of SKOV-3 ovarian cancer cells.
    Whitley BR; Beaulieu LM; Carter JC; Church FC
    Gynecol Oncol; 2007 Feb; 104(2):470-9. PubMed ID: 17070899
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Binding of urokinase to plasminogen activator inhibitor type-1 mediates cell adhesion and spreading.
    Planus E; Barlovatz-Meimon G; Rogers RA; Bonavaud S; Ingber DE; Wang N
    J Cell Sci; 1997 May; 110 ( Pt 9)():1091-8. PubMed ID: 9175705
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Sphingosine-1-phosphate and interleukin-1 independently regulate plasminogen activator inhibitor-1 and urokinase-type plasminogen activator receptor expression in glioblastoma cells: implications for invasiveness.
    Bryan L; Paugh BS; Kapitonov D; Wilczynska KM; Alvarez SM; Singh SK; Milstien S; Spiegel S; Kordula T
    Mol Cancer Res; 2008 Sep; 6(9):1469-77. PubMed ID: 18819934
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Phosphatidylinositol 3-kinase/protein kinase Akt negatively regulates plasminogen activator inhibitor type 1 expression in vascular endothelial cells.
    Mukai Y; Wang CY; Rikitake Y; Liao JK
    Am J Physiol Heart Circ Physiol; 2007 Apr; 292(4):H1937-42. PubMed ID: 17172275
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Cell adhesion regulates the plasminogen activator inhibitor-1 gene expression in anchorage-dependent cells.
    Lee CC; Shyu KG; Lin S; Wang BW; Liu YC; Chang H
    Biochem Biophys Res Commun; 2002 Feb; 291(1):185-90. PubMed ID: 11829481
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Osteopontin: it's role in regulation of cell motility and nuclear factor kappa B-mediated urokinase type plasminogen activator expression.
    Das R; Philip S; Mahabeleshwar GH; Bulbule A; Kundu GC
    IUBMB Life; 2005 Jun; 57(6):441-7. PubMed ID: 16012053
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Hypoxia-inducible factor-1 and hypoxia response elements mediate the induction of plasminogen activator inhibitor-1 gene expression by insulin in primary rat hepatocytes.
    Kietzmann T; Samoylenko A; Roth U; Jungermann K
    Blood; 2003 Feb; 101(3):907-14. PubMed ID: 12393531
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Akt kinase targets association of CBP with SMAD 3 to regulate TGFbeta-induced expression of plasminogen activator inhibitor-1.
    Das F; Ghosh-Choudhury N; Venkatesan B; Li X; Mahimainathan L; Choudhury GG
    J Cell Physiol; 2008 Feb; 214(2):513-27. PubMed ID: 17671970
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Effects of transforming growth factor-beta 1 and phorbol ester on PAI-1 and PA genes in human lung cells.
    Jakowlew SB; Mariano JM; You L
    Growth Factors; 1997; 14(2-3):177-97. PubMed ID: 9255608
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Immunohistochemical demonstration of the plasminogen activator system in human gingival tissues and gingival fibroblasts.
    Xiao Y; Bunn CL; Bartold PM
    J Periodontal Res; 1998 Jan; 33(1):17-26. PubMed ID: 9524317
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Modulation of tissue plasminogen activator and plasminogen activator inhibitor-1 by transforming growth factor-beta in human retinal glial cells.
    Schacke W; Beck KF; Pfeilschifter J; Koch F; Hattenbach LO
    Invest Ophthalmol Vis Sci; 2002 Aug; 43(8):2799-805. PubMed ID: 12147618
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Biphasic regulation of plasminogen activator/inhibitor by LDL in mesangial cells.
    Song CY; Kim BC; Hong HK; Kim BK; Kim YS; Lee HS
    Am J Physiol Renal Physiol; 2002 Sep; 283(3):F423-30. PubMed ID: 12167592
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Prostaglandin E2 regulates production of plasminogen activator isoenzymes, urokinase receptor, and plasminogen activator inhibitor-1 in primary cultures of rat calvarial osteoblasts.
    Allan EH; Martin TJ
    J Cell Physiol; 1995 Dec; 165(3):521-9. PubMed ID: 7593231
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Transcriptional regulation of plasminogen activator inhibitor-1 expression by insulin-like growth factor-1 via MAP kinases and hypoxia-inducible factor-1 in HepG2 cells.
    Dimova EY; Möller U; Herzig S; Fink T; Zachar V; Ebbesen P; Kietzmann T
    Thromb Haemost; 2005 Jun; 93(6):1176-84. PubMed ID: 15968405
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Fibrinolytic activity of human mesothelial cells is counteracted by rapid uptake of tissue-type plasminogen activator.
    Sitter T; Toet K; Quax P; Kooistra T
    Kidney Int; 1999 Jan; 55(1):120-9. PubMed ID: 9893120
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Activation of the {beta}-catenin/T-cell-specific transcription factor/lymphoid enhancer factor-1 pathway by plasminogen activators in ECV304 carcinoma cells.
    Maupas-Schwalm F; Robinet C; Augé N; Thiers JC; Garcia V; Cambus JP; Salvayre R; Nègre-Salvayre A
    Cancer Res; 2005 Jan; 65(2):526-32. PubMed ID: 15695395
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.